Many compounds of plant origin have been identified that inhibit different stages in the replication cycle of human immunodeficiency virus (HIV): 1) virus adsorption: chromone alkaloids (schumannificine), isoquinoline alkaloids (michellamines), sulphated polysaccharides and polyphenolics, flavonoids, coumarins (glycocoumarin, licopyranocoumarin) phenolics (caffeic acid derivatives, galloyl acid derivatives, catechinic acid derivatives), tannins and triterpenes (glycyrrhizin and analogues, soyasaponin and analogues); 2) virus-cell fusion: lectins (mannose-and N-acetylglucosamine-specific) and triterpenes (betulinic acid and analogues); 3) reverse transcription: alkaloids (benzophenanthridines, protoberberines, isoquinolines, quinolines), coumarins (calanolides and analogues), flavonoids, phloroglucinols, lactones (protolichesterinic acid), tannins, indoids (fulvoplumierin) and triterpenes; 4) integration: coumarins (3-substituted-4-hydroxycoumarins), depsidones, O-caffeoyl derivatives, lignans (anctigenin and analogues) and phenolics (curcumin); 5) translation: single chain ribosome inactivating proteins (SCRIP's); 6) proteolytic cleavage (protease inhibition):
Introduction
Acquired immunodeficiency syndrome (AIDS) is a pandemic immunosuppressive disease which results in life-threatening opportunistic infections and malignancies. Since a retrovirus, designated human immunodeficiency virus (HIV), has been clearly identified as the primary cause of this disease, numerous compounds including also plant-derived substances have been evaluated for their inhibitory effects on HIV replication in vitro (1).
According to De Clercq (2) the replicative cycle of HIV comprises ten steps that could be considered adequate targets for chemotherapeutical intervention. Most of the anti-HIV plant-derived compounds can be assigned to one of these ten classes of HIV inhibitors according to the stage at which they interfere with the HIV replicative cycle, i.e., adsorption, fusion, uncoating, reverse transcription, integration, DNA replication, transcription, translation, maturation and budding (assembly! relase).
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(3). Isolated from the root bark of Schumanniophyton magnifiaim the chromone secondary amine, schumannificine (2) , displayed the greatest activity against HIV, whereas potent anti-herpes simplex (anti-HSV) activity was observed for a number of its derivatives. Th presence of a piperidine ring and unsubstituted hydroxy groups on the molecules seemed to favour the anti-HIV activity, which is considered to be due to irreversible binding to gp120 rather than inhibition of reverse transcriptase or protease (4).
The well-known benzylisoquinoline alkaloid, papaverine (3), has been shown to have a potent inhibitory effect on the replication of several viruses inicuding cytomegalovirus (CMV), measles and HIV. It was suggested that the compound affected the expression of HIV proteins, especially of the envelope precursor protein gp120 (5).
In a report involving a limited number of patients, recovery of immunological cutaneous responsiveness was noted after administering papaverine orally for four weeks. This also was associated with a 50% improvement in their absolute T4 cells counts (6) . Preliminary experiments indicate that the combination of suboptimal concentrations of both papaverine and AZT enhanced their inhibitory effects on HIV replication and HIV-induced cytopathic effects. The fact that papaverine has potent antiviral effects against CMV in vitro might make it attractive for use in combination therapy of AIDS patients with CMV disease. Three novel anti-HIV atropisomeric naphthylisoquinoline alkaloid dimers, michellamines A, B and C, have recently been obtained from the tropical liana Aristocladus korupensis from the rainforest of Cameroon. Despite relatively modest potency, all three compounds were capable of complete inhibition of the cytopathic effects of HIV-1 and HIV-2 on human lymphoblastoid target cells in vitro (7) . Biochemical studies of the mechanism of action of the most potent and abundant member of the series, michellamine B (4), showed that this alkaloid acts both at an early stage of the HIV-life cycle by inhibiting reverse transcriptase (RT) as well as at later stages by inhibiting cellular fusion and syncyticum formation. Because of its unusual structure, broad range of anti-HIV activity, chemical stability and solubility, michellamine B has been committed to preclinical drug development by the National Cancer Institute (NCI, USA) (8) .
A number of alkaloids has been reported to inhibit HIVinfectivity by inhibiting the nitrogen-linked glycosylation process of HIV. Castanospermine (5), a tetrahydroxyindolizidine first isolated from the seeds of Castanospermum australe (9) and more recently from Alexia sp. (10) is a potent inhibitor of a-and /3-n-glucosidases and several disaccharidases (11). It has been shown to display in vitro antiviral activity against retroviruses, including Rauscher murine leukemia (12) , Mobney murine leukemia virus (13) and HIV (14) . Castanospermine has been shown to inhibit the activity of a-glucosidase I, the enzyme which is responsible for the cleavage of the terminal a-glucose unit and thus initiates the trimming of the N-linked oligosaccharides.
In addition to castanospermine also 6,7-diepicastanospermine (15) and several polyhydroxylated pyrrolizidine alkaloids such as australine (6) and analogues and alexine (16) , showing varying degrees of inhibitory activity against glycosi-dases, have been isolated from Castanospermum australe and Alexia leopetala (10) . The piperidine alkaloids including 1deoxynojirimicin (7) and a-homonojirimicin (8) from Omphalea diandra (17) were also glycosidase inhibitors, whereas the analogue 1-deoxymannojirimicin (9) rather interfered with mannosidase (18) . All these alkaloids inhibit HIV infectivity, albeit at relatively high concentrations (0.1 to 10 mM). The attenuated infectivity of HIV particles released from chronically infected cells that have been exposed to the glycosylation inhibitors is paralleled by reduced binding of these virions to the cells and, consequently, syncytium formation (19) .
Castanospermine, when given orally at doses as high as 100 or 400 mg/kg/day, was found to inhibit Rauscher leukemia virus-induced splenomegaly by 37 and 78 %, respectively; however, when compared with AZT in the same murine system, castanospermine was less active and more toxic (12) .
In patients, gastrointestinal side effects such as diarrhea, flatulence and abdominal pain have been noted with an Nbutyl analogue of 1-deoxynojirimicin (SC-48334) given orally at 1000mg every 8 hours (20) . These problems would be caused by the inhibitory effect of SC-48334 on the intestinal a-glucosidases such as maltase and sucrase and might be overcome by prodrugs, i.e., N-butyl-1 -deoxynojirimicin-6phosphate (SC-49955) which do not inhibit gut a-glucosidase.
Admittedly, these prodrugs must be able to cross the intestinal barrier before they are hydrolysed so as to release the active compound N-butyl-1-deoxynojirimicin (2).
Out of 156 pure natural products which have been tested by Tan et al. (21) benzophenanthridine alkaloids such as fagaronine (10) and nitidine (11), which are known inhibitors of avian myeloblastosis virus RT (22) and protoberberine alkaloids such as columbamine (12) , berberine (13) , palmatine (14) and coralyne (15), which are known inhibitors of RNA tumour viruses (23) demonstrated potent anti-HIV-1 RT activity. Additional inhibitors found were the isoquinoline alkaloids psychotrine (16) and its 0-methyl ether. All these alkaloids caused enzyme inhibition by interacting with the template primers, particularly those of the adenine-thymine base pairs (24) . It was further shown that the inhibitory activity correlates well with the antileukemic effects in mice. grifolan have been suiphated to variable degrees to afford suiphated analogues, which inhibit l-IIV replication in vitro at concentrations that are up to 10,000-fold lower than the cytotoxic concentration.
These compounds are targeted at the interaction between the viral envelope glycoprotein gpl2O and the CD4 receptor, and as a consequence, they inhibit not only virus adsorption to the cells but also virus-induced syncytium (giant cell) formation. The inhibitory effects of dextran sulphate and its congeners on viral binding, viral replication and syncytium formation appear to be mediated by a specific interaction with the V3 region of gpl2O (2) . In addition, suiphated polysaccharides may also directly interfere with the binding of HIV particles to the heparin sulphate proteoglycan of the cell surface, whether or not this process occurs independently of, or cooperatively with, the viral envelope-CD4 receptor interaction (29) .
Dextran sulphate is poorly adsorbed after oral administration and upon intravenous administration produces thrombocytopenia, so that there is little, if any, evidence for the in vivo efficacy of this compound and more generally of sulphated polysaccharides against HIV infection. Therefore one should consider their potential application in the (systemic) prophylaxis of HIV following an accidental needle stick injury or stab wound, i.e., conditions in which azidothymidine (AZT) has proved inefficacious and/or topical prophylaxis of HIV or HSV infection contracted through sexual intercourse (2) .
It should be noticed that sulphated polymers owe their anti-HIV activity to the presence of the sulphate groups, which in turn are responsible for the inhibition of virus-cell binding. In this sense, any compound could be turned into an anti-l-IlV agent targeted at viruscell binding provided it contains the necessary hydroxy groups for attachment of the sulphate groups. In the last years several sulphated plant phenolics such as tannic acid sulphate, rutin sulphate, ellagic acid sulphate, (-)-epicatechin sulphate, (-)-epigallocatechin gallate sulphate and pentagalloylglucose sulphate have been synthesized (1). All these compounds were found to be inhibitory to HIV in vitro due to inhibition of viral adsorption to CD4-positive cells.
Preliminary in vivo studies in mice infected with HIV-1 revealed that HIV replication was significantly suppressed by sulphated pentagalloylglucose (21) (Y-ART-3), after intravenous administration of 4mg/kg. The compound also showed to be more stable in an effective form in the bloodstream than dextran sulphate (30) .
In a pilot investigation using acemannan (Carrisyn), a polymannogalactoacetate from Aloe barbadensis, in the treatment of AIDS, McDaniel et a!. treated a total of 53 patients over a period of 3 months. Acemannan treatment significantly improved clinical and laboratory parameters in these patients, while no prominent toxic effects were noted. The mode of action of acemannan against HIV infection has been seen as a combination of destruction of infected or defected cells due to activation of killer cells, production of non-infective, defective HIV virus, enhanced antibody production and increased host surveillance for other antigenic substances (31) .
The mannose-specific plant lectins, e.g., from Cymbidium hybrid, Epipactis helleborine, Hippeastrum hybrid and Listeria ovata and the N-acetylgiucosamine-specific plant lectins, e.g., from Urtica dioica qualify as specific inhibitors of the virus cell-fusion process; they do not inhibit virus attachment to the cells, yet they block syncytium formation between l-IlVinfected cells and uninfected cells (32) . Those plant lectins that inhibit syncytium formation also inhibit I-fly replication, and it is likely that they intervene at the fusion step of HIV replication. This may also be the case for the mannose-specific lectins from Gerardia savaglia (33) and Machaerium sp. (34).
Mannose-and N-acetylglucosamine-specific plant lectins may be assumed to interact with specific glycosylation sites within the viral envelope glycoproteins gp120 and/or gp4l, particularly those sites that are rich in mannose or Nacetylglucose. These plant lectins were also found to inhibit a number of other viruses, so that they should be further pursued for their therapeutic potential in the treatment of retro-, herpes-and myxoviruses in vitro (2) .
Coumarins
Coumarins such as calanolides (35) and inophyllums (36) have been established as non-nucleoside specific inhibitors of HIV-l-RT. Calanolides A and B, isolated from the leaves of a tropical rainforest tree Calophyllum lanigerum collected in Sarawak, Malaysia, provided complete protection against the in vitro replication and cythopathicity of HIV-1 in lymphoblastic cells, but were inactive against HIV-2 or avian myeloblastosis virus (AMy). Further studies revealed that calanolides A and B effectively inhibit the DNA-dependent DNA polymerase and RNA-dependent DNA-polymerase activities of HIV-1-RT, so that their interactions with HIV-1-RT may be distinct from that of other non-nucleoside HIV-1-RT inhibitors; in particular, a segment located between amino acids 225 and 425 in HIV-1-RT may be important for specifying susceptibility to these substances (37). Moreover, calanolide A was not only active against AZT-resistant G-9106 strain of HIV-1 but also against the pyridone-resistant A17 strain, the latter being highly resistant to previously known HIV-1 specific nonnucleoside RT inhibitors such as TIBO and nevirapine (35).
On the basis of these findings (+)-calanolide A (22) , being the most potent calanolide, has been committed to preclinical drug development by the US Nd. As with many natural products, the procurement of adequate supplies of (+ )calanolide A for detailed biological evaluation has proved to be quite challenging, especially since it has been shown that only (+)-calanolide A and (-)-calanolide B, also known as costatolide (23) (+ )-Calanolide A is only a minor compound of the leaves of Colophyllum lanigerum (<1 mg/g extract) and although a synthesis of racemic calanolide A has been reported (39) a chiral synthesis is not yet available. Costatolide, however, was identified as the major active constituent from a tropical rainforest tree Calophyllum teysmannii being abundantly present in the latex (48% of latex extractables) (40) . A related coumarin, soulattrolide (24) , is also a major component (ca.
29% of latex extractables) in the latex of the same tree (41). In comparative anti-HIV tests, soulattrolide was found to mediate a response similar to calanolide B, but it was somewhat less potent than costatolide (Ed50 0.341tM). Consequently, Semi-synthetic anticoagulants such as warfarin and phenprocoumon were found to strongly inhibit cell-free and cellmediated HIV-infection (43). It is now known that these anticoagulants inhibit the vitamin K-dependent conversion of prothrombine to an active form as well as the enzymatic activity of the serine-protease, thrombine. It was, therefore, not too surprising to find that these coumarins are competitive micromolar inhibitors of HIV-1 protease, an enzyme which is essential for proper virion assembly and maturation of HIV. Structural analogues of both compounds indicate that the pyran-2-one group, the 4-hydroxy group and substitution at the 3-position are all necessary for inhibitor activity (44). Recently, it was discovered that 3-substituted 4-hydroxycoumann derivatives not only inhibit HIV-protease but also HIVintegrase (IN), an enzyme necessary for the integration of viral DNA (45), so that they may provide lead compounds for the development of novel antiviral agents, based upon the concurrent inhibition of two viral targets, HIV-1 integrase and protease (46) . (27) consistently exhibited the highest activity, EC50 of 1 pg/ml and selectivity index (SI) > 100, and was somewhat more active than (-)-epicatechin. Differences between isomers were noted in the lower activity of (-)-epigallocatechin in contrast to (+ )-gallocatechin.
Of seventeen flavones only myricetin (SI = 20) and the 3-0glycosides of kaempferol (28) , quercetin (29) and myricetin (30) caused significant inhibition of HIV-1 infection at nontoxic concentrations. None of the flavanones selectively inhibited HFV-1 replication. On the contrary, these compounds were generally more cytotoxic than the flavan and flavone derivatives studied. The inhibitory action of these substances was shown to be non-specific and was principally due to a more selective interaction with gpl2O. In this respect the anti-HIV action of these flavonoids is similar to the actions of polyanionic compounds such as sulphated polysaccharides and various tannins, which interact irreversibly with gpl2O to block virus infection (47).
In addition to two coumarins, also three flavonoids with in vitro anti-HIV activity namely licochalcone A (31), isolicoflavonol (32) and glycyrrhizoflavone (33), have been isolated from Glycyrrhiza glabra. They seem to block giant-cell formation in HIV-infected cell cultures as well (42) . Numerous reports claim that an aqueous-alkali treatment of previously extracted pine cones affords after fractionation a "lignin-related" isolate, containing high molecular weight substances, i.e., KS-6 and KS-7 having antiviral and antitumour activities (57). These substances also had immunopotentiating effects and induced macrophage differentiation, whereas cytotoxicity was relatively low (58) . Recently, Eberhardt and Young (59) provided the first definitive evidence by thioacido-Iysis for a phenylpropanoid, i.e., lignin component in this isolate which may provide the observed anti-HIV-1 activity for this substance.
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Also dehydrogenatiori polymers of cinnamic acid derivatives, which seem to be similar to ligneous material, and can be synthesised in the presence of peroxydase and hydrogen peroxide (MW = 800-150,000) show anti-HIV activity by preventing the binding of gp120 to the CD4 receptor (60) .
Phenolics
The caffeoylquinic acids, 3,4,5-tri-O-caffeoylquiriic acid (3,4,5-TCQA) (45) and 4,5-di-O-caffeoylquinic acid (4,5-DCQA), isolated from Securidaka longipedunculata and some galloylquinic acids such as 3,4,5-tri-O-galloylquinic acid (3,4,5-TGQA) from Guiera senegalensis are selective inhibitors of HIV with SI of 300,67 and 94, respectively (61).
Previously, similar phenolics including 1,3,4-TGQA (46), 3,5-0digalloylshikimic acid (3,5-DGSA) (47), 3,4,5-TGSA (62) and several tetragalloylquinic acids (63) were shown to selectively inhibit 1-IIV-replication and to inhibit HIV-RT in vitro. However, their ability to inhibit cellular DNA polymerases was inconsistent with specific inhibition of the virus enzyme. It was then also reported that inhibition of I-IIV-RT in vitro by caffeoyl-and galloylquinic acid is non-specific and that inhibition of virus infection is due to interaction of the compounds with gpl2O, preventing virus binding to the CD4 receptor (61). The same mode of action was also found for the anti-HIV active monosodium and monopotassium salts of isomeric caffeic acid tetramers, isolated from Arnebia euchoma (64) .
The antiviral action of these compounds is not peculiar to HIV since they exhibit even greater activity against HSV-1 infection. Their ability to bind irreversibly to gpl2O and inactivate virus infectivity make these agents suitable candidates for investigating their potential in counteracting sexual trans- Three new prenylated catechol dimers, namely peltatols A (48), B and C have been isolated from the tropical shrub Pothomorpha peltata, growing in the Dominican Republic.
These compounds inhibit HIV-1 induced cell killing at subtoxic concentrations of 1 -10 ig/ml. The monomeric catechol derivative 4-nerolidylcatechol was inactive in the anti-HIV screen, however, it did weakly block phorbol receptor binding (69) .
Gossypol (49), a polyphenolic aldehyde extracted from cottonseed is active against enveloped viruses, including HIV (70) . Evaluation of the two pure enantiomers showed the (-)enantiomer of gossypol to be very inhibitory (EC50 = 1.0-5.OpM), whereas the (+)-enantiomer was much less active (EC50 = 50-1001iM). Since gossypol was quite cytotoxic in cell cultures, several analogues were prepared in order to increase the Sl (71) . Although differences in inhibition of cytotoxicity were found, none was of the magnitude to justify further study, so that its potential application is only to be considered as an external virucidal agent.
Other plant-derived phenolics with anti-HIV RT activity include several phloroglucinol derivatives such as mallotojaponin (50) and mallotochromene (51), both isolated from the pericarps of Mallotus japonicum (72) and an aliphatic amethylene-y-lactone, protolichesterinic acid (52) isolated from the lichen Cetraria islandica (52) . Immunotoxins prepared from ricin, a toxic two chain RIP isolated from Ricinus communis, have been used in the clinical treatment of cancer patients. Later on, immunoconjugates containing monoclonal antibodies specific for the envelope protein gp4l of HIV linked to the ricin A chain have been shown to kill HIV-infected T cells and monocytes (80) . Inhibition of protein synthesis, cell growth and viral production was also observed when a conjugate with antibody against the gpl2O glycoprotein was tested in l-IIV-infected cells (81) . These compounds would have the capacity to block viral assembly in (or release from) infected cells as well as directly inactive properly assembled (or released) virions (84) . Visible light is essential for all of the antiviral effects of these compounds. Upon illumination with visible light, these compounds inactivate enveloped, but not unenveloped viruses and thus act as virucidal agents (85) . Only when the concentration of hypericin approached the cytotoxic level was there an apparent light-independent antiviral effect (86) .
Proteins

Quinones/Xanthones
1-lypericin is known to form triplets and to generate singlet oxygen with high efficiency, which may play a role in the antiviral activity of this compound, but as has been shown recently it does not play a major role (87) .
Hypericin inhibits also protein kinase C (P1(C) activity and epidermal growth factor receptor tyrosine kinase activity. While hypericin may be a suitable agent for photodynamic inactivation of enveloped viruses in blood and blood products, it is hard to conceive how this compound could be useful in the systemic treatment of HIV-infected patients (2) .
Recently, two related xanthones, namely mangostin and ymangostin, isolated from Garcinia mangostana, have been found as active constituents against HIV-1 protease. The type of inhibition by both compounds is non-competitive (88) .
Phospholipids
Several phospholipid formulations including phosphatidylcholine, phosphatidylinositol and phosphatidylethanolamine, purified from soy bean, exhibited anti-H IV activity in different test systems at relatively high but apparently non-toxic concentrations (IC50 = 16-2OpM). Phospholipids containing two sites of urisaturation in the fatty acid moiety are active while phospholipids containing only fully saturated fatty acids did not exhibit any anti-HIV activity (89) . The mode of action of these compounds may relate to the accumulation of toxic metabolic products into the membranes of the virus after the hydrolysis of these compounds by phospholipase A-2 (90) .
Photosensitisers
Photosensitisers of a variety of chemical families have demonstrated clearly that, when in association with cells or cell membranes and when activated at an appropiated wavelength of light, a photodynamic mechanism is initiated which usually results in the destruction of the cell. The mechanism by which the cell destruction occurs is thought to involve mainly the generation of singlet oxygen which interacts with cellular components, including lipids and proteins. In the case of many photosensitisers, which have been tested both in vitro and in vivo, the photodynamic attack appears to take place mainly in association with membranes. Membrane disruption with concomitant leakage of intracellular material and loss of cell function leads to cell death (82) .
Several classes of photosensitisers including terthiophenes,
i.e., sulfur-containing heterocyclic compounds that are widely distributed among species of the Asteraceae, furoisocoumarins and porphyrins have been evaluated for activity against HIV.
The furoisocoumarin, coriandrin (56), isolated from Conandrum sativum, the thiarubines A (57) and D (dithiocyclohexadienes) obtained from Chenactisdouglasii and a-terthienyl (a-T) (58), a trithiophene obtained from Tagetes sp., showed prominent anti-HIV activity in the presence of long wavelength light (UVA, 320-400 nm). The compounds had little or no activity in visible light or in the dark. The anti-HIV effect was UVA-dose dependent and was proportional to the concentration of the substances, according to several parameters of virus infectivity and replication. The efficacy of all products was decreased to some extent by the presence of bovine or human serum in the reactions, which suggests that the compounds may have a certain affinity for certain protein or lipid materials (91, 92).
Of these photodynamic agents a-terthienyl is the most potent antiviral phytochemical and should be evaluated further for its potential use in the decontamination of blood products, where a number of viruses, including retroviruses, constitute potential hazards (86) .
Tannins
Several of the virucidal plant compounds are tannins or related phenolic substances, which are often responsible for the virucidal effects in several viral systems, found for tea as well as juices and beverages prepared from common fruits (93) . In general, it is believed that polyphenols act by associating with proteins of viral particles and/or host cell surfaces, resulting in a reduction or prevention of viral adsorption. should be noted that even at high concentrations these tannins did not completely inhibit HIV binding. It was subsequently found that the dimeric hydrolysable tannins are potent inhibitors of poly (ADP-ribose) glucohydrolase, an enzyme that plays a regulatory role in gene transcription (95).
Kakiuchi et al. (96) found that hydrolysable tannins including gallotannins and ellagitannins were potent inhibitors of RI from avian myeloblastosis virus (AMV) due to an interference of the template-primer-enzyme nucleotide complex. Dimeric ellagitannins, including among others coriariin A (64) and agrimoniin (65) were more effective inhibitors than monomeric ellagitannins, and trigalloylglucose and tetragalloylglucose were less effective than the gallotannins with a larger number of galloyl residues such as hepta-and octagalloylglucoses.
Dimeric ellagitannins such as oenothein B were also found to inhibit replication of HIV (97). The inhibitory action was ascribed to inhibition of both viral adsorption and RIinhibitory activity. Mouse sera obtained after oral administration of oenothein B also inhibited HIV and HSV replications.
Other inhibitors of HIV-RT are the gallotannins punicalin, punicacortein, sanguin H-li, (62) and shephagenins A and B (98) , ellagic acid (66) (99) and digallic acid (67) (100).
Investigation of eighteen condensed tannins on RT from avian myeloblastosis virus showed galloylated catechin and epica- Interestingly, it was found that the methanolic extract of Combretum micranthum is only active against enveloped viruses such as l-IIV and HSV when it is kept for seven days. On standing the inactive condensed tannins are cleaved under alkaline conditions to their monomers, which undergo a spontaneous intramolecular rearrangement into catechinic acid (69) . Auto-oxidation in alkaline medium of catechinic acid gives rise to the formation of polyphenol radicals which undergo a variety of reactions to give antivirally active polymers through C-C and C-O couplings. These oxidised polymerisates are named auto-oxidised catechinic acid (AO-CA) and can also be prepared by bubbling air through an alkaline solution of catechinic acid at different temperatures (102) .
AOCA, especially the polymers with Mr between 10,000 and 30,000, showed prominent anti-HIV properties with low cytotoxicity, probably by acting in the first stage of infection and thereby inhibiting virus penetration into the cells. These polymers were also found to be active in vitro against HSV-1 and HSV-2 (102).
Terpenes
Glycyrrhizin (70), one of the main saponins of Glycyrrhiza glabra inhibits the growth of a number of DNA and RNA viruses including HIV I in vitro (103) . In Japan, glycyrrhizin has been studied in AIDS patients. It was claimed that, when given orally to asymptomatic I-IIV carriers, the substance delayed the progression of symptoms related to HIV. It was also claimed that, when administered intravenously for a period of more than a month, to hemophilics with AIDS, viral antigen considerably decreased, suggesting that glycyrrhizin might inhibit HIV replication in vivo. In another claim simultaneous administration of the compound appeared to decrease the adverse reactions of zidovudine (104) .
Recently, glycyrrhizin was tested in a murine AIDS model Investigations on the mechanism of action of giycyrrhizin suggested that the compound, being a polyanionic substance, interferes with virus adsorption, which is further complemented by an inhibitory effect on PKC. This enzyme seems to be required for the binding of HIV I particles to the cellular CD4 receptors (106) .
Although giycyrrhizin itself did not show any significant effect on viral reverse transcriptase its sulphate was an inhibitor.
This substance was estimated to be four times as potent as its parent natural compound in anti-HIV studies (107) .
Also other saponins including saponin B1 from soybean (108), fusion step, required for virus entry into the cells (113) .
Extensive structure-activity relationship studies were carried out leading to the synthesis of a series of w-aminoalkanoic acid derivatives of betulinic acid. The anti-H'V 1 activity of several members of this new series was found to be in the nanomolar range in CEM-4 and MT-4 cell cultures (114) .
Further mechanistic studies ruled out an interference with the binding of gpl2O in the CD4 molecule or in a cellular context. Moreover, betulinic acid derivatives were able to block efficiently syncyticum formation of CD4 cells mediated by the HIV-1 envelope glycoproteins, which confirm the interaction of these substances with the post-binding viruscell fusion process (115) .
Plant-derived terpenic RT-inhibitors that have been reported are the iridoid, fulvoplumierin (78) (21) and the triterpenes, 1-J3-hydroxyaleuritolic acid-3-p-hydroxybenzoate (79) from Maprounea africana (52) , and nigranoic acid (80) from Schisandra sphaerandra (116).
Also several steroidal alkaloids such as buxamine E (81) and cyclobuxamine H (82) from Buxus sempervirens have been shown to inhibit HIV-1 RTas well as TNF(1).
Conclusion
As evident from this review, there is now considerable evidence emerging not only from the many reports and Other interesting leads for the development of antiviral drugs include a large variety of secondary plant metabolites that exhibit competitive in vitro and in viva antiviral activities comparable with those found for synthetic counterparts which are in various stages of development. These natural products have shown to interfere with many viral targets ranging from adsorption of the virus to the host cells to release from it, which can result in mechanisms of action complementary to those of existing antiviral drugs.
Examples are virus adsorption inhibitors such as sulphated polysaccharides, saponins and phenolic plant components, virus-cell fusion inhibitors such as mannose-and N-acetylglucosamine-specific plant lectins and betulinic acid derivatives, reverse transcriptase inhibitors such as flavones, fla-vans, phloroglucinols and isoquinoline alkaloids, translation inhibitors such as trichosanthin and other single-chain ribosome inactivating plant proteins, maturation inhibitors such as castanospermine, 1-deoxynojirimicin and analogues, and budding (assembly/release) inhibitors such as hypericin and other photosensitisers.
In conclusion, several plant-derived antiviral agents are prime candidates to be pursued for their potential in the systemic therapy and/or prophylaxis of HIV infections. Some of them might be useful as topical agents to inactivate newly formed virus or as adjuvants in combination with other antiviral drugs. It is, however, essential that the plant kingdom as source of new antiviral leads should be explored further and that these investigations should be encouraged and continued.
